Long Covid patients suffer from chronic symptoms such as fatigue or shortness of breath. As researchers have discovered, this is to some extent due to a part of our immune system called the complement ...
Commit Biologics has completed a $60 million seed financing to advance its complement-powered immune engager pipeline toward ...
Researchers discovered that complement immune proteins prompt immune cells to absorb cancer-targeting nanoparticles, ...
A scientific review details how epigenetic mechanisms influence complement system activity and tissue vulnerability across ...
COM002 is a first-in-class complement-powered immune engager based on Commit Biologics proprietary BiCE platform.Anne-Marie Levy Rasmussen appointed Chief Operating ...
COPENHAGEN, Denmark, March 11, 2026 (GLOBE NEWSWIRE)-- Commit Biologics ("Commit"), a biotechnology company pioneering complement system activation and backed by €21.5 million in seed financing from ...
Most people infected with the SARS-CoV-2 virus recover after the acute illness. However, a significant proportion of infected individuals develop long-lasting symptoms with a wide range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results